Therapeutic Drug Monitoring (TDM) Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 2,000.00$ 6,900.00

Global Therapeutic Drug Monitoring (TDM) Market By Technology (Immunoassays, LC-MS/MS, GC/GC-MS, and Others), By Drug class (Antibiotics, Immunosuppressants, Addiction Therapeutics, Analgesics, Anti Cancer, Alzheimer Disease, Analeptics, Anti-coagulants, Anti-hypertensive, Anti-Depressants, Anti- Psychotics, Hormones, Anti-Epileptic Drugs, Anti-Arrhythmic Drugs and Anti-Fungals), and By Geography (North America, Latin America, Europe, Asia Pacific and Middle East and Africa)

 

$ PRICE - $ 2,000.00$ 6,900.00
Clear selection
Clear
$ PRICE - $ 2,000.00$ 6,900.00
FacebookTwitterLinkedinEmail

Report

Description

Global Therapeutic Drug Monitoring Market size was valued at USD 1900 Million in the year 2020 and is anticipated to value at USD 2746 Million till 2027 witnessing a CAGR rate of 5.4% during the forecast period 2021-2027. Therapeutic Drug Monitoring is a measurement of drug concentrations or drug metabolites in plasma. It is usually carried out for narrow therapeutic index drugs. Therapeutic drug monitoring is the clinical assessment of drug’s pharmacokinetic properties. TDM helps in reduce drug toxicity, enhance drug efficacy and diagnostic purpose. Various drug molecules usually monitored at clinical practice. For example: drugs like digoxin, cyclosporin, phenytoin, carbamazepine and valproic acid, among others. Tricyclic antidepressants (TCAs) such as Amitriptyline, Nortriptyline, Imipramine, and Clomipramine are frequently preferred for TDM due to their slow onset of action the difficulty of assessing dose-effect, and the marked interindividual variability of steady-state plasma concentration. In general, LC-MS/MS is highly preferred for TDM of tricyclic antidepressants due to structural similarity of the drugs. Immunosuppressant drugs are mostly used in organ transplantation cases. Patients using ISD’s commonly undergo TDM owing to their narrow therapeutic index, variability in blood concentrations between individuals and severe adverse effects.

 

In terms of technology, LC-MS/MS accounts for more than USD 730 Million in 2018 followed by immunoassay, Others and GC/GC-MS. In terms of value, LC-MS/MS dominate the global TDM market followed by the immunoassays segment owing to its sensitivity, specificity towards the identification analytes and simultaneous analysis of the multiple drugs and analytes in the blood. However, in terms of volume Immunoassays dominate the market and they are cost effective when compared with other reagents. The report gives historical, current, and future market sizes (US$ Bn) based on Technology, Drug class, and Geography. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.


Global Therapeutic Drug Monitoring (TDM) Market

MARKET SUMMARY
-
5.4% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 5.4%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Global Therapeutic Drug Monitoring (TDM) Market

  • In 2018, more than 400 Million TDM tests were conducted around the globe and projected to reach more than 600 Million TDM tests by 2028. Immunoassay and LC-MS/MS are the top technology platforms for analyzing the TDM samples and they both analyzed more than 250 Million TDM samples in 2018.
  • North America TDM market has a market share of 56% in 2018 followed by EMEA with 31.2%. USA dominates the therapeutic drug monitoring market in North America and global level.
  • The top four drug classes: Antidepressants, Immunosuppressants, Hormones, and Analgesics accounts to have 55.7% market share in the global therapeutic drug monitoring market.
  • Among the antidepressants, Citalopram is highly preferred for TDM due to the racemic mixture of the compound. Moreover, the elimination half-life for the drug is approximately 33 hours
Market Leaders
  • ARK Diagnostics, Inc.
  • Beckman Coulter
  • Ortho Clinical Diagnostics
  • Sekisui Diagnostics
  • SJK Global, LLC
  • Chromsystems
  • Meridian Healthcare S.R.L.
  • Randox Laboratories Ltd
  • Sekisui Medical Co. Ltd.
  • Thermo Fisher Scientific
Drivers and Restrains

Global Therapeutic Drug Monitoring (TDM) Market

Increase in the number of organ transplantation cases around the globe expected to fuel the therapeutic drug monitoring over the forecast period. As per the World Health Organization (WHO), in November 2016, approximately 100,791 people await kidney transplants and Over 3,000 new patients are added to the kidney waiting list each month. Moreover, adverse effects associated with the drugs, and development of technologically advanced instruments are enables the growth of therapeutic drug monitoring market over the forecast years. Moreover, rise in R&D activities for the development of test kits, rise in adoption of therapeutic drug monitoring in emerging countries, and development in healthcare infrastructure are anticipated to propel the global therapeutic drug monitoring market over the forecast years.


North America accounted for larger revenue share

Global Therapeutic Drug Monitoring (TDM) Market

North America accounted for larger revenue share in global therapeutic drug monitoring market with moderate CAGR. Increase in the adoption of therapeutic drug assays by the healthcare professionals, innovation of advanced test kits by the market players, and surge in prevalence of chronic diseases are boost the market in the region. Asia Pacific market projected to grow at significant rate owing to increase in number of patients with chronic diseases in India, China, and japan, development in healthcare infrastructure, and launch of newer test kits into market are expected to enhance the market over the forecast timeframe.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Therapeutic Drug Monitoring (TDM) Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

Table of Content

  1. Executive Summary
  2. Global Therapeutic Drug Monitoring (TDM) Market Introduction
    • Global Therapeutic Drug Monitoring (TDM) Market – Taxonomy
    • Global Therapeutic Drug Monitoring (TDM) Market –Definitions
      • Drug Type
      • Technology
  1. Global Therapeutic Drug Monitoring (TDM) Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
  2. Global Antibiotics Therapeutic Drug Monitoring (TDM) Market, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • Chloramphenicol
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Linezolid
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Piperacillin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Rifampicin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Tazobactam
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Vancomycin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Gentamicin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Amikacin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Tobramycin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Meropenem
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Naficillin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Addiction Therapeutics Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2018 – 2028 (Revenue, USD Mn)
    • Buprenorphine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Methadone
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Naltrexone
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Tapentadol
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Analgesics Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • Paracetamol
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Ibuprofen
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Naproxen
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Aspirin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Tramadol
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Anticancer Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • 5-Fluorouracil
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Docetaxel
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Methotrexate
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Paclitaxel
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Imatinib
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Busulfan
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Alzheimer’s Disease Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2018 – 2028 (Revenue, USD Mn)
    • Donepezil
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Galantamine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Memantine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Analeptics Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • Caffeine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Theophylline
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Antiarrhythmic Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • Amiodarone
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Digoxin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Flecainide
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Mexiletine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Verapamil
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Digitoxin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Lidocaine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Anticoagulants Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • Dabigatran
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Warfarin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Antihypertensive Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • Propranolol
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Antidepressant Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • Citalopram
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Fluoxetine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Fluvoxamine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Sertraline
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Venlafaxine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Trazodone
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Protriptyline
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Nortryptiline
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Imipramine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Desipramine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Doxepin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Clomipramine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Bupropion
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Amitriptyline
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Antiepileptic Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • Ethosuximide
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Felbamate
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Gabapentin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Lamotrigine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Pregabaline
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Topiramate
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Zonisamide
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Carbamazepine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Valproic Acid
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Lacosamide
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Levetiracetam
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Phenobarbital
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Phenytoin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Rufinamide
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Tiagabine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Vigabatrin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Anti-HIV Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • Atazanavir
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Indinavir
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Lopinavir
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Nelfinavir
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Ritonavir
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Saquinavir
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Darunavir
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Fosamprenavir
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Tipranavir
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Efavirenz
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Etravirine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Nevirapine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Rilpivirine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Psychotic Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • Aripiprazole
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Clozapine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Haloperidol
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Olanzapine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Ziprasidone
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Chlorpromazine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Lithium
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Lurasidone
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Paliperidone
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Perphenazine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Quetiapine
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Risperidone
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Thiothixene
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Hormones Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • T4
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • T3
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • TSH
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Immunosuppressants Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • Cyclosporin A
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Everolimus
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Mycophenolic Acid
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Sirolimus
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Tacrolimus
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
  1. Global Anti-Fungal Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
    • Fluconazole
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Itraconazole
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Voriconazole
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Posaconazole
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Anidulafungin
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
    • Ketoconazole
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2028 (Revenue, USD Mn)
      • Technology Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028
      • Regional Analysis (Value and Volume), 2014-2018 and Forecast 2019 – 2028


Report

Company Profile

  • ARK Diagnostics, Inc.
  • Beckman Coulter
  • Ortho Clinical Diagnostics
  • Sekisui Diagnostics
  • SJK Global, LLC
  • Chromsystems
  • Meridian Healthcare S.R.L.
  • Randox Laboratories Ltd
  • Sekisui Medical Co. Ltd.
  • Thermo Fisher Scientific
  • North American Science Associates, Inc.
  • Ortho Clinical Diagnostics, Randox Laboratories Ltd
  • Alfa Scientific Designs, Inc.
  • Carolina Liquid Chemistries
  • Concateno (Alere)
  • DiaSystem Scandinevia AB
  • First Check Diagnostics
  • Alfa Scientific Designs, Inc.
  • Orasure Technologies, Inc

Description

Global Therapeutic Drug Monitoring Market size was valued at USD 1900 Million in the year 2020 and is anticipated to value at USD 2746 Million till 2027 witnessing a CAGR rate of 5.4% during the forecast period 2021-2027. Therapeutic Drug Monitoring is a measurement of drug concentrations or drug metabolites in plasma. It is usually carried out for narrow therapeutic index drugs. Therapeutic drug monitoring is the clinical assessment of drug’s pharmacokinetic properties. TDM helps in reduce drug toxicity, enhance drug efficacy and diagnostic purpose. Various drug molecules usually monitored at clinical practice. For example: drugs like digoxin, cyclosporin, phenytoin, carbamazepine and valproic acid, among others. Tricyclic antidepressants (TCAs) such as Amitriptyline, Nortriptyline, Imipramine, and Clomipramine are frequently preferred for TDM due to their slow onset of action the difficulty of assessing dose-effect, and the marked interindividual variability of steady-state plasma concentration. In general, LC-MS/MS is highly preferred for TDM of tricyclic antidepressants due to structural similarity of the drugs. Immunosuppressant drugs are mostly used in organ transplantation cases. Patients using ISD’s commonly undergo TDM owing to their narrow therapeutic index, variability in blood concentrations between individuals and severe adverse effects.

 

In terms of technology, LC-MS/MS accounts for more than USD 730 Million in 2018 followed by immunoassay, Others and GC/GC-MS. In terms of value, LC-MS/MS dominate the global TDM market followed by the immunoassays segment owing to its sensitivity, specificity towards the identification analytes and simultaneous analysis of the multiple drugs and analytes in the blood. However, in terms of volume Immunoassays dominate the market and they are cost effective when compared with other reagents. The report gives historical, current, and future market sizes (US$ Bn) based on Technology, Drug class, and Geography. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX